Academic clinical lecturer post ⁦in #Neurology ⁦Imperial Department of Brain Sciences⁩ with a focus on #Dementia & opportunities to work with colleagues across ⁦Imperial College London⁩ and 2 ⁦UK Dementia Research Institute⁩ Centres. Please RT and do get in touch if interested! oriel.nhs.uk/Web/Vacancy/Va…

Thanks Asian Voice for the coverage of the role that the Blood Biomarker challenge grant award will play in bringing accurate dementia diagnosis to local communities in the UK, and for featuring the ADAPT study. asian-voice.com/News/UK/HOPE-F… Research at ARUK Alzheimer's Society

Indian-origin neurologist Ashvini Keshavan's UK study to revolutionise dementia diagnosis

#Neurology #dementia #Alzheimers #healthcare
newsdrum.in/international/…

A world-class research team UCLH and UCL Queen Square Institute of Neurology led by Jonathan Schott & Ashvini Keshavan has been awarded £3.76m to carry out a nationwide trial to identify accurate and quick blood tests that can diagnose dementia.

uclhospitals.brc.nihr.ac.uk/news/blood-tes…

Alzheimer's Society Alzheimer's Research UK NIHR Research

Honoured to be co-leading the ADAPT study of plasma p-tau217 in the UK with Jonathan Schott, bringing together expertise from UCL in dementia research DRC@UCL, nationally accredited lab UCLh, patient&public engagement University of Kent, cost-effectiveness LSE

Alzheimer's Association #pTau round Robin study
⬇️⬇️⬇️

Jonathan Schott Ashvini Keshavan

Don’t miss The Basics of Biofluid Based Biomarkers PIA: Core CSF Biomarkers and Analytics on April 25. Hear a presentation of content from moderator Charlotte Teunissen and panelists Alicia Algeciras-Schimnich, Ph.D. & Markus Otto, M.D., with a quiz and Q&A. Register: bit.ly/41B3EUj

There’s still time to register for The Basics of Biofluid Based Biomarkers PIA on April 7! Join for a look into the basics of core blood biomarkers and analytics, featuring panel moderator Charlotte Teunissen with panelists Ulf Andreasson, Ph.D. & Inge Verberk. Register: bit.ly/3MaT6Xp

📅27 Apr 2pm Preparing for Disease Modifying Therapies for Dementia: implications for research, trials & clinical services UCL Queen Square Institute of Neurology 🟧 Hilary Evans-Newton 🟧 Kate Lee Jonathan Schott Cath Mummery🍊 Gill Livingston @RabLab_UCSF Jonathan Graff-Radford great programme & speakers

dementiaresearcher.nihr.ac.uk/event/preparin…

Brilliant outline of research priorities for AD BBM field; particularly need for studies of 1. diverse, real-world clinical application: first memory clinic, then primary care 2. robustness & certified ref materials 3. Impact of pre analytics & comorbidities

Coming out in print this month! Recommended reading particularly for Neurology Trainees Association of British Neurologists

Looking forward to this AD blood biomarker-themed journal club hosted by #FluidmarkersPIA today where our ⁦Brain⁩ paper on screening for preclinical AD will be discussed; do register and join us!

Our Practical Neurology “How to do it” covers CSF service design, assays, cutpoint interpretation; hope useful to all caring for those with dementia in neurology, psychiatry, elderly care, where more biomarker-supported diagnosis needed ABN Cognitive SIG Royal College of Physicians Royal College of Psychiatrists

Can’t recommend a more productive, cohesive and friendly team to work with - having been one of these fellows I can say it really has made my last few years! And in the wider context of the DRC UCL Queen Square Institute of Neurology you will stand to learn so much as a clinician.

We have launched a new page on research on our website: theabn.org/page/ABNT-rese… with info on:
•How to get started
•Funding
•Mentorship
and many other useful things! Come visit and spread the word to your colleagues!